01 November 2008
The US Court of Appeals for the Federal Circuit has ruled that a $398 million deal between a patent owner and generic pharmaceutical companies does not violate competition law, in the latest controversial case over reverse payments to be decided...
Log in
Join here
July /August 2019
AI and IP: the view from above
Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable
Switching to MIP International